BMCBIOCHEM . BIOMEDCENTRAL . COM {
}
Title:
The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells | BMC Biochemistry | Full Text
Description:
Background To investigate the roles of androgen receptor (AR) in epithelial- mesenchymal transition (EMT) in human prostate cancer stem progenitor (S/P) cells isolated from LNCaP cell line. Methods The S/P cells were obtained from LNCaP cell line through florescence-activated cell sorting (FACS). AR was overexpressed in S/P cells through lentivirus. Western blot assay was used to detect the EMT markers expression, such as E Cadherin, N Cadherin, Vimentin and Snail. MTT assay, soft agar colony formation assay, sphere formation assay and migration assay were used to investigate AR’s roles in EMT of S/P cells. Cell signaling pathways associated with proliferation and apoptosis of S/P cells were detected simultaneously. And S/P cells were treated with in vitro combinatory use of LY 294002 (inhibitor of AKT signaling molecules) with γ-TT and/or 5-AZA. Results Our data showed that S/P cells from LNCaP had high EMT markers expression, more tumorigenesis and strong migration ability. And in S/P cells overexpressed with AR, the expression of EMT markers decreased. In addition, these cells had less proliferation ability, tumorigenesis ability, self-renewal and migration ability. At the same time, targeting S/P cells with AKT signaling pathway inhibitor LY29004 andγ-TT and/or 5-AZA could inhibit S/P cell’s proliferation and tumorigenesis. Conclusions Our data suggest that AR played a negative role in EMT of PCa S/P cells, by regulating AKT cell signaling pathway, which could be a new strategy to treat castration resistant prostate cancer (CRPC).
Website Age:
25 years and 10 months (reg. 1999-08-06).
Matching Content Categories {📚}
- Science
- Telecommunications
- Social Networks
Content Management System {📝}
What CMS is bmcbiochem.biomedcentral.com built with?
Custom-built
No common CMS systems were detected on Bmcbiochem.biomedcentral.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of bmcbiochem.biomedcentral.com audience?
🚗 Small Traffic: 1k - 5k visitors per month
Based on our best estimate, this website will receive around 1,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Bmcbiochem.biomedcentral.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (3)
yourbow.com, google.com, doceree.comHow Much Does Bmcbiochem.biomedcentral.com Make? {💰}
Display Ads {🎯}
$80 per month
Our calculations suggest that Bmcbiochem.biomedcentral.com earns between $51 and $139 monthly online from display advertisements.
Keywords {🔍}
bmc, cookies, privacy, cells, cadherin, page, data, optional, content, analysis, personal, parties, policy, information, manage, biochemistry, cell, vimentin, assay, counted, article, contact, editing, authors, choice, essential, make, site, function, advertising, personalisation, usage, social, media, accepting, consent, processing, including, transfers, european, economic, area, varying, standards, protection, preferences, change, choices, accept, skip,
Topics {✒️}
authors scientific editing privacy choices/manage cookies bmc european economic area androgen receptor plays epithelial- mesenchymal transition lncap cell line western blot analysis state privacy rights accepting optional cookies 1471-2091 contact manage preferences personal data migration assay optional cookies data protection essential cookies usage analysis cookies skip cell extracts cookies policy privacy policy privacy statement social media varying standards suppressive role emt characteristics staining results humidified incubator colonies larger migrative potential average number random fields general enquiries preference centre springer nature content choices privacy cells choice make site function advertising personalisation consent processing parties information
Schema {🗺️}
WebPage:
mainEntity:
headline:The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells
description:To investigate the roles of androgen receptor (AR) in epithelial- mesenchymal transition (EMT) in human prostate cancer stem progenitor (S/P) cells isolated from LNCaP cell line. The S/P cells were obtained from LNCaP cell line through florescence-activated cell sorting (FACS). AR was overexpressed in S/P cells through lentivirus. Western blot assay was used to detect the EMT markers expression, such as E Cadherin, N Cadherin, Vimentin and Snail. MTT assay, soft agar colony formation assay, sphere formation assay and migration assay were used to investigate AR’s roles in EMT of S/P cells. Cell signaling pathways associated with proliferation and apoptosis of S/P cells were detected simultaneously. And S/P cells were treated with in vitro combinatory use of LY 294002 (inhibitor of AKT signaling molecules) with γ-TT and/or 5-AZA. Our data showed that S/P cells from LNCaP had high EMT markers expression, more tumorigenesis and strong migration ability. And in S/P cells overexpressed with AR, the expression of EMT markers decreased. In addition, these cells had less proliferation ability, tumorigenesis ability, self-renewal and migration ability. At the same time, targeting S/P cells with AKT signaling pathway inhibitor LY29004 andγ-TT and/or 5-AZA could inhibit S/P cell’s proliferation and tumorigenesis. Our data suggest that AR played a negative role in EMT of PCa S/P cells, by regulating AKT cell signaling pathway, which could be a new strategy to treat castration resistant prostate cancer (CRPC).
datePublished:2015-05-06T00:00:00Z
dateModified:2015-05-06T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12858-015-0042-9
keywords:
Prostatic neoplasms
Stem progenitor cell
Epithelial-mesenchymal transition
Androgen receptor
Biochemistry
general
Life Sciences
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig5_HTML.gif
isPartOf:
name:BMC Biochemistry
issn:
1471-2091
volumeNumber:16
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ma Zhifang
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Wei Liang
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Zhang Wei
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Hao Bin
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Tu Rui
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Wu Nan
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Zhang Shuhai
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells
description:To investigate the roles of androgen receptor (AR) in epithelial- mesenchymal transition (EMT) in human prostate cancer stem progenitor (S/P) cells isolated from LNCaP cell line. The S/P cells were obtained from LNCaP cell line through florescence-activated cell sorting (FACS). AR was overexpressed in S/P cells through lentivirus. Western blot assay was used to detect the EMT markers expression, such as E Cadherin, N Cadherin, Vimentin and Snail. MTT assay, soft agar colony formation assay, sphere formation assay and migration assay were used to investigate AR’s roles in EMT of S/P cells. Cell signaling pathways associated with proliferation and apoptosis of S/P cells were detected simultaneously. And S/P cells were treated with in vitro combinatory use of LY 294002 (inhibitor of AKT signaling molecules) with γ-TT and/or 5-AZA. Our data showed that S/P cells from LNCaP had high EMT markers expression, more tumorigenesis and strong migration ability. And in S/P cells overexpressed with AR, the expression of EMT markers decreased. In addition, these cells had less proliferation ability, tumorigenesis ability, self-renewal and migration ability. At the same time, targeting S/P cells with AKT signaling pathway inhibitor LY29004 andγ-TT and/or 5-AZA could inhibit S/P cell’s proliferation and tumorigenesis. Our data suggest that AR played a negative role in EMT of PCa S/P cells, by regulating AKT cell signaling pathway, which could be a new strategy to treat castration resistant prostate cancer (CRPC).
datePublished:2015-05-06T00:00:00Z
dateModified:2015-05-06T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12858-015-0042-9
keywords:
Prostatic neoplasms
Stem progenitor cell
Epithelial-mesenchymal transition
Androgen receptor
Biochemistry
general
Life Sciences
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig5_HTML.gif
isPartOf:
name:BMC Biochemistry
issn:
1471-2091
volumeNumber:16
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ma Zhifang
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Wei Liang
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Zhang Wei
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Hao Bin
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Tu Rui
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Wu Nan
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Zhang Shuhai
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:BMC Biochemistry
issn:
1471-2091
volumeNumber:16
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Ma Zhifang
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
email:[email protected]
name:Wei Liang
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Zhang Wei
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Hao Bin
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Tu Rui
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Wu Nan
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Zhang Shuhai
affiliation:
name:First Hospital of Shanxi Medical University
address:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
External Links {🔗}(20)
- What is the earnings of https://www.biomedcentral.com/privacy-statement?
- How much does https://www.biomedcentral.com net monthly?
- Find out how much https://www.biomedcentral.com/journals earns monthly
- https://www.biomedcentral.com/getpublished income
- What's the financial gain of https://www.biomedcentral.com/about?
- How much does https://www.biomedcentral.com/account make?
- How much does https://blogs.biomedcentral.com/ make?
- How much revenue does https://www.biomedcentral.com/login bring in?
- Financial intake of https://authorservices.springernature.com/go/sn/?utm_source=Website&utm_medium=BMC&utm_campaign=SNAS+Referrals+2022&utm_id=ref2022
- What's the monthly money flow for https://www.biomedcentral.com/about/policies?
- What's the revenue for https://www.biomedcentral.com/accessibility?
- https://www.biomedcentral.com/about/press-centre's total income per month
- How much does https://support.biomedcentral.com/support/home bring in each month?
- https://biomedcentral.typeform.com/to/VLXboo's revenue stream
- What's the financial intake of https://www.biomedcentral.com/about/jobs?
- http://www.weibo.com/biomedcentral income
- What are the total earnings of https://www.biomedcentral.com/terms-and-conditions?
- What is the earnings of https://www.springernature.com/ccpa?
- Discover the revenue of https://www.biomedcentral.com/cookies
- Monthly income for https://www.springernature.com
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
CDN Services {📦}
- Crossref